Invivyd (IVVD) Non Operating Income (2021 - 2025)
Invivyd (IVVD) reported Non Operating Income of $1.5 million for Q4 2025, up 88.93% on a YoY basis from $786000.0 in Q4 2024, and up 168.54% quarter-over-quarter from $553000.0 in Q3 2025.
Invivyd (IVVD) Non Operating Income (2021 - 2025) Analysis & Trends
Invivyd has reported Non Operating Income for 5 years, with the latest figure at $1.5 million in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income rose 88.93% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at $3.1 million (down 55.82% YoY), and the FY2025 full-year result was $3.1 million, down 55.82% from the prior year.
- Non Operating Income for Q4 2025 stood at $1.5 million, up from $553000.0 in the prior quarter.
- The five-year high for Non Operating Income was $3.8 million in Q1 2023, with the low at $9000.0 in Q1 2021.
- Historically, Non Operating Income has averaged $1.5 million across 5 years, with a median of $1.1 million in 2024.
- Annual changes were most pronounced in 2022 — Non Operating Income soared 7479.17% — and 2025, when it slumped 80.0%.
- Invivyd's Non Operating Income stood at $48000.0 in 2021, then soared by 7479.17% to $3.6 million in 2022, then declined by 14.84% to $3.1 million in 2023, then tumbled by 74.63% to $786000.0 in 2024, then surged by 88.93% to $1.5 million in 2025.
- The last three Non Operating Income figures came in at $1.5 million (Q4 2025), $553000.0 (Q3 2025), and $400000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | 1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.49 Mn |
| Sep 30, 2025 | 553,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 633,000.00 |
| Dec 31, 2024 | 786,000.00 |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 3.62 Mn |
| Jun 30, 2023 | 3.65 Mn |
| Mar 31, 2023 | 3.75 Mn |
| Dec 31, 2022 | 3.64 Mn |
| Sep 30, 2022 | 2.24 Mn |
| Jun 30, 2022 | 759,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | 43,000.00 |
| Jun 30, 2021 | 18,000.00 |
| Mar 31, 2021 | 9,000.00 |